To add to your thoughts on these natural substances and
To add to your thoughts on these natural substances and their ability to serve medicinal purposes, many of these powders/oils/etc do have evidence of efficacy but it's usually in some lab or poorly designed "study" and they're often not ultimately doing a damn thing when we take them. Besides maybe a meager placebo effect.
Take Saw Palmetto as an example. Constantly touted as an effective treatment for BPH (enlarged prostate and the symptoms that accompany it). I once spoke to a very well respected hospital's chief of naturopathy about it. He'd looked into it, along with many other things with optimism and vigor because that was job to do so. Spoiler alert, he said it did nothing.
From WebMD:
Saw palmetto: This is a short tree that grows in North America. Some small studies have shown a benefit. However, several large studies do not show that saw palmetto reduces the size of the prostate or eases urinary symptoms.
The way he explained it was that for the supposed effects to show up you'd have to take a dose that's unreasonable to both produce and consume, and even then it's arguable whether or not it would do anything.
It's like all of the covid "cures" and "promising treatments" coming out of the woodwork. Jlang could set up a petri dish in his van down by an undisclosed river and subject it to readings of his past posts, and the virus would probably die in vitro. Or kill itself* to end the misery.
*Oh shit! I think I may have inadvertently created a cure for Covid you guys!
Many things can work in a lab or a mouse and ultimately have zero effect in humans. Natural remedies are our best example of that.
Now that I've pointed that out I'll admit that some things can and do work, they're just the exception. Hell, I used to sell a drug called Condylox Gel that killed wart tissue. It was specifically tested and approved based on trials for genital warts, but like those who contract genital warts it was taking all comers (heyooo) and would work on regular old warts too. It killed the tissue. Nobody knew exactly why, but it was derived from a flower (or plant, I can't be bothered to look it up right now) and that's some powerful flower assassin type shit. They could make a hell of a CSI episode around that flower. #FlowerPower #TissueDeath
At any rate, there are plenty of things that will likely work just as much as natural cures and I've listed a couple below.
- Snorting Pixy Stix
- Rubbing yourself in Respert's preferred steak seasoning, Chicago Steak by - - - Weber
- Watching JLang lose to Ohm and CTMedic in a science battle
- Putting people on ignore that deserve it
- Flaming Dr. Peppers
#TechnicalAnalysis
12
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
A New Era in 3D Model Accessibility Unless you’ve been hiding under a rock, it’s hard to miss how digital terraforming has shifted gears. With Hi3D V1.0 opening its doors, the playing field's getting a major reshuffle. Or, as they say, the table is being set, and everyone's getting a seat. By letting loose production-validated AI tools, Hi3D is throwing down the...
Continue Reading
Unicycive's Tumultuous Journey Lately, it's been a rocky road for Unicycive Therapeutics, Inc., with their stock free-falling 39.1% in the span of a heartbeat on June 30, 2026. What sparked this nosedive? The FDA kicked back their revised New Drug Application for a kidney disease treatment yet again, spotlighting old manufacturing issues never nipped in the bud. Talk...
Continue Reading
You've got to hand it to New York City—this isn't just another Tuesday twist. The City Council's decision to nix horse-drawn carriages is like throwing a wrench in an antique machine. It's a bold move in a concrete jungle that's constantly wearing new coats. Tradition vs. Welfare: The Crux For years, the idea of horses prancing down NYC streets seemed like a quaint nod...
Continue Reading
Getting the Cards Out: Maneuvering the Holiday Hustle Alright, let's dive into the madness that is holiday card season. Could be a logistical nightmare or a nostalgic tradition, depending on your cup of tea. Basic Invite here is trying to cut through the chaos by bumping deadlines and offering some straight-out-the-gate mailing options. If you play your cards right—pun...
Continue Reading
Investors Eye December 15 Deadline Nothing like a looming deadline to stir up some anxiety among investors, and that's exactly what's going down at D-Wave Quantum Inc. right now. We're talking about the class action lawsuit spearheaded by the firm Robbins Geller Rudman & Dowd LLP. They've sent out a call to arms for investors who suffered significant losses from February...
Continue Reading
A Legendary Career in Palliative Medicine You know, in a world where people glamorize stock flips and flashy earnings, it's refreshing to spotlight good old-fashioned compassion. Enter Dr. Alexander Trost, DNP, FNP-C, ACHPN. This fella has just been honored as a Pinnacle Lifetime Member by The Inner Circle—a nod to his impactful work in palliative medicine. You ever try...
Continue Reading
Trouble Brewing for Tigo Energy? Straight from the horse's mouth, we hear about Tigo Energy (NASDAQ: TYGO) getting embroiled in a class action smackdown. Picture it: Tigo fumbles their projections, and boy does it sting. They're caught in the crossfire for allegedly puffing up their revenue expectations tied to a venture with EG4 Electronics—poised to churn out...
Continue Reading
Food Safety Breakthrough: Youth Leads the Charge When it comes to food safety, it’s about time the younger crowd gets their due. The latest crew to step up to the plate is the Class of 2026's 40 Under 40 Food Safety Professionals. They’re not just pushing paper; these folks are setting the bar high and innovating across continents with real, tangible changes. From...
Continue Reading
An Anticipated Unveiling Ellington Financial Inc. (NYSE:EFC) is gearing up to spill the beans on its third-quarter financials for 2026. It's all going down after the markets close on November 4th. I can tell you, folks, anyone keeping an eye on EFC will be itching to know what's inside those numbers. With a company this deep into financial assets, reading between the...
Continue Reading
Riding the Wave of Profit in Micromobility Sometimes all you need is a quick jolt of genius to turn the wheels of fortune. Dott seems to have hit that sweet spot in Q3 of 2026. Deploying 45,000 new vehicles wasn’t just a logistical feat; it was a calculated bet that paid off handsomely, bolstering their business to soaring heights. Performance that Packs a Punch The Q3...
Continue Reading
Top 5 Most Recently Viewed Articles
ComFree's Return to the Market After a notable absence, ComFree is back, igniting excitement in the real estate industry. The company's founders, Erin and Travis Holowach, originally created ComFree as a platform for homeowners to sell properties without agent interference, saving them significant fees. Their mission is now revitalized as they reclaim the brand they built...
Continue Reading
The average federal income tax paid by a typical person ranges from 13.5% to 15%, and tax planning is a mathematical necessity for anyone serious about building long-term wealth in the United States. Every dollar lost to an inefficient exit from an investment is a dollar that stops compounding for your future self. There are thousands of taxable events triggered daily...
Continue Reading
Biomea Fusion Unveils Promising Efficacy of Icovamenib Biomea Fusion, Inc. (Nasdaq: BMEA), a pioneer in clinical-stage advancements for diabetes and obesity, recently announced significant 52-week results from its Phase II COVALENT-111 study. This study examined the potential effects of icovamenib, a novel treatment for type 2 diabetes (T2D), and the results underscore a...
Continue Reading
D-Wave Quantum Under Legal Microscope Alright, folks, let's dive headfirst into some dicey financial waters with D-Wave Quantum Inc. (NASDAQ: QBTS). This quantum computing company is finding itself in a bit of a pickle following some rough second-quarter results that left investors scratching their heads. If you bought into the hype and are feeling the sting in your...
Continue Reading
Groundbreaking Launch of DeriW Exchange DeriW, an innovative decentralized perpetual exchange, has officially launched during an exclusive event, showcasing its advanced features and capabilities. The event, hosted by CoinW, attracted 400 influential figures from the cryptocurrency sector. Among the attendees were thought leaders, blockchain pioneers, and affiliates, all...
Continue Reading